Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease.

Trevor L Schell,Keith L Knutson,Sumona Saha,Arnold Wald,Hiep S Phan,Mazen Almasry,Kelly Chun,Ian Grimes,Megan Lutz,Mary S Hayney,Francis A Farraye,Freddy Caldera

Inflammatory bowel diseases（2022）

引用 21|浏览22

暂无评分

摘要

Lay Summary Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.

查看译文

关键词

COVID-19 vaccine,Crohn’s disease,inflammatory bowel disease,ulcerative colitis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要